摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2′-O-(苄氧羰基)紫杉醇 | 148930-30-7

中文名称
2′-O-(苄氧羰基)紫杉醇
中文别名
——
英文名称
2’-carboxybenzoylpaclitaxel
英文别名
2'-benzyloxycarbonyl-paclixatel;2'-Z-paclitaxel;2'-O-(Benzyloxycarbonyl)taxol;2'-benzyloxycarbonyltaxol;[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-3-phenyl-2-phenylmethoxycarbonyloxypropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
2′-O-(苄氧羰基)紫杉醇化学式
CAS
148930-30-7
化学式
C55H57NO16
mdl
——
分子量
988.055
InChiKey
VWNYXOYSAFBZTM-XXWNPYBWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    1020.4±65.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿、DCM、乙酸乙酯、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    72
  • 可旋转键数:
    19
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    237
  • 氢给体数:
    3
  • 氢受体数:
    16

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: Evaluation of novel conjugates as cytotoxic agents
    摘要:
    Sixteen different taxoid conjugates were prepared by linking various anticancer compounds, including camptothecin (CPT), epipodophyllotoxin (EP), colchicine (COL), and glycyrrhetinic acid (GA), at the 2'- or 7-position on paclitaxel (TXL, 1) through an ester, imine, amine, or amide bond. Newly synthesized conjugates were evaluated for cytotoxic activity against replication of several human tumor cell lines. Among them, TXL-CPT conjugates, 8-10, were more potent than TXL itself against the human prostate carcinoma cell line PC-3 (ED50 = 14.8, 3.1, 19.4 nM compared with 55.5 nM), and conjugate 10 was also 8-fold more active than TXL against the LN-CAP prostate cancer cell line. These compounds also possessed anti-angiogenesis ability as well as lower inhibitory effects against a normal cell line (MRC-5). Thus, conjugates 8-10 are possible antitumor drug candidates, particularly for prostate cancer. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.02.051
  • 作为产物:
    描述:
    在 palladium on activated charcoal N-碘代丁二酰亚胺 、 4 A molecular sieve 、 氢气N,N-二异丙基乙胺过氧化苯甲酰 作用下, 以 四氢呋喃二氯甲烷乙酸乙酯乙腈 为溶剂, 37.0 ℃ 、413.69 kPa 条件下, 反应 7.0h, 生成 2′-O-(苄氧羰基)紫杉醇
    参考文献:
    名称:
    Synthesis and antitumor evaluation of paclitaxel phosphonooxymethyl ethers: a novel class of water soluble paclitaxel pro-drugs
    摘要:
    The synthesis, pharmacokinetic properties, and antitumor evaluation of novel paclitaxel phosphonooxymethyl ether derivatives 8-11 and salts thereof is described. These compounds exhibit improved water solubility as compared to paclitaxel (1) and upon incubation with plasma and alkaline phosphatase they readily release parent drug. The in vivo antitumor evaluation of compounds 8-11 established them as suitable pro-drugs of paclitaxel. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0960-894x(96)00321-6
点击查看最新优质反应信息

文献信息

  • Phosphonooxy and carbonate derivatives of taxol
    申请人:Bristol-Myers Squibb Company
    公开号:US05272171A1
    公开(公告)日:1993-12-21
    The present invention is directed to novel taxol derivatives useful as anti-tumor agents. Also provided by this invention is pharmaceutical formulations and methods of treating mammalian tumors with the compounds of this invention.
    本发明涉及新型紫杉醇生物,可用作抗肿瘤药物。本发明还提供了药物配方和使用本发明化合物治疗哺乳动物肿瘤的方法。
  • Synthesis and Biological Evaluation of a Biotinylated Paclitaxel with an Extra-Long Chain Spacer Arm
    作者:Lev. G. Lis、Mary A. Smart、Anna Luchniak、Mohan L. Gupta、Vadim J. Gurvich
    DOI:10.1021/ml300149z
    日期:2012.9.13
    A biotinylated paclitaxel derivative with an extra-long chain (LC-LC-biotin) spacer arm was synthesized using an improved synthetic reaction sequence. The biotinylated paclitaxel analogue retained excellent microtubule stabilizing activity in vitro. Furthermore, it was shown that this analogue can simultaneously engage streptavidin and the binding site on microtubules, making it suitable for localization
    使用改进的合成反应序列合成了具有超长链(LC-LC-生物素)间隔臂的生物素化紫杉醇生物生物素化的紫杉醇类似物在体外保留了极好的微管稳定活性。此外,该类似物可以同时结合链霉亲和素和微管上的结合位点,使其适用于定位研究或通过链霉亲和素键将紫杉醇连接到固体基质上。
  • Fluoro taxols
    申请人:Bristol-Myers Squibb Company
    公开号:US05294637A1
    公开(公告)日:1994-03-15
    This invention relates to a fluorinated taxol of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.z is RO-- or R; R.sup.g is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, furyl, thienyl or phenyl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups; R.sup.2 is --OCOR, H, OH, --OR, --OSO.sub.2 R, --OCONR.sup.o R, --OCONHR, --OCOO(CH.sub.2).sub.t R, or --OCOOR; and R and R.sup.o are independently C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.3-6 cycloalkyl, C.sub.2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups. Further provided by this invention are pharmaceutical formulations and useful intermediates for the fluorinated taxols of formula I. A method of treating mammalian tumors using a compound of formula I is also provided.
    本发明涉及一种化学式为I的紫杉醇,其中R.sup.1是--COR.sup.z,其中R.sup.z为RO--或R;R.sup.g为C.sub.1-6烷基,C.sub.2-6烯基,C.sub.2-6炔基,C.sub.3-6环烷基,或具有--W--R.sup.x的基团,其中W是键,C.sub.2-6烯二基,或--(CH.sub.2).sub.t--,其中t为1至6;R.sup.x为基,呋喃基,噻吩基或苯基,此外R.sup.x还可以选择地用一个至三个相同或不同的C.sub.1-6烷基,C.sub.1-6烷氧基,卤素或--CF.sub.3基团取代;R.sup.2为--OCOR,H,OH,--OR,--OSO.sub.2 R,--OCONR.sup.o R,--OCONHR,--OCOO(CH.sub.2).sub.t R,或--OCOOR;R和R.sup.o分别为C.sub.1-6烷基,C.sub.2-6烯基,C.sub.3-6环烷基,C.sub.2-6炔基,或苯基,可选地用一个至三个相同或不同的C.sub.1-6烷基,C.sub.1-6烷氧基,卤素或--CF.sub.3基团取代。此外,本发明还提供了该化学式I的紫杉醇的药物制剂和有用的中间体。同时也提供了使用化学式I化合物治疗哺乳动物肿瘤的方法。
  • 7,8-cyclopropataxanes
    申请人:Bristol-Myers Squibb Company
    公开号:US05254580A1
    公开(公告)日:1993-10-19
    An antitumor compound of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.z is t-butyloxy, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups; R.sup.2 is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, furyl, thienyl or phenyl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups; R.sup.3 is OCOR, --OCOOR, H, or OH; R.sup.4 is hydrogen; or R.sup.3 and R.sup.4 jointly form a carbonyl group; and R is C.sub.1-6 alkyl. Also provided by this invention are pharmaceutical formulations (compositions) and a method of treating mammalian tumors with a compound of formula I.
    公式I的抗肿瘤化合物为 ##STR1## 其中 R.sup.1 为 --COR.sup.z,其中 R.sup.z 为 t-丁氧基,C.sub.1-6烷基,C.sub.2-6烯基,C.sub.2-6炔基,C.sub.3-6环烷基或苯基,可选地取代一个至三个相同或不同的C.sub.1-6烷基,C.sub.1-6烷氧基,卤素或--CF.sub.3基团; R.sup.2 为C.sub.1-6烷基,C.sub.2-6烯基,C.sub.2-6炔基,C.sub.3-6环烷基或公式--W--R.sup.x的基团,其中W为键,C.sub.2-6烯二基或--(CH.sub.2).sub.t --,其中t为1至6;且R.sup.x为基,呋喃基,噻吩基或苯基,此外,R.sup.x还可以选择性地取代一个至三个相同或不同的C.sub.1-6烷基,C.sub.1-6烷氧基,卤素或--CF.sub.3基团; R.sup.3为OCOR,--OCOOR,H或OH; R.sup.4为氢; 或R.sup.3和R.sup.4共同形成一个羰基团; 而R为C.sub.1-6烷基。本发明还提供了公式I的化合物的制药配方(组成)和治疗哺乳动物肿瘤的方法。
  • The chemistry of taxanes: reaction of taxol and baccatin derivatives with Lewis acids in aprotic and protic media
    作者:Shu-Hui Chen、Stella Huang、Jianmei Wei、Vittorio Farina
    DOI:10.1016/s0040-4020(01)80381-1
    日期:1993.4
    proceed via anchimeric assistance by the C-4 acetate group. Several minor products, including a novel derivative possessing a bridged C-ring, were also isolated. A mechanistic rationale is provided for all compounds formed. When taxol derivatives were treated with Lewis acids in methanol, ester cleavage reactions were observed. We provide conditions that are selective for C-10 acetate cleavage and
    几种路易斯酸被证明可以完全打开紫杉醇和浆果赤霉素生物的氧杂环丁烷环。已表明该反应是通过C-4乙酸酯基团通过邻氨基苯甲酸协助进行的。还分离了几种次要产物,包括具有桥C环的新型衍生物。提供了所形成的所有化合物的机械原理。当在甲醇中用路易斯酸处理紫杉醇生物时,观察到酯裂解反应。我们提供对C-10乙酸酯裂解和C-13侧链甲醇裂解具有选择性的条件。
查看更多